175 related articles for article (PubMed ID: 32035135)
21. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity.
Sad S; Krishnan L; Bleackley RC; Kägi D; Hengartner H; Mosmann TR
Eur J Immunol; 1997 Apr; 27(4):914-22. PubMed ID: 9130644
[TBL] [Abstract][Full Text] [Related]
22. Enhanced CD8
Parasa VR; Forsslund H; Enger T; Lorenz D; Kullberg S; Eklund A; Sköld M; Wahlström J; Grunewald J; Brighenti S
Respir Med; 2018 May; 138S():S38-S44. PubMed ID: 29055517
[TBL] [Abstract][Full Text] [Related]
23. Notch signaling pathway dampens tumor-infiltrating CD8
Yu W; Wang Y; Guo P
Biomed Pharmacother; 2018 Jan; 97():535-542. PubMed ID: 29096354
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
Hokuto D; Sho M; Yamato I; Yasuda S; Obara S; Nomi T; Nakajima Y
Eur J Cancer; 2015 Jan; 51(2):157-65. PubMed ID: 25468715
[TBL] [Abstract][Full Text] [Related]
25. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
26. Notch regulates cytolytic effector function in CD8+ T cells.
Cho OH; Shin HM; Miele L; Golde TE; Fauq A; Minter LM; Osborne BA
J Immunol; 2009 Mar; 182(6):3380-9. PubMed ID: 19265115
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the cytotoxic response mediated by perforin and granzyme B in patients with non-Hodgkin lymphoma.
Souza BMB; De Vito FB; Calado ML; Silva MV; Oliveira LR; Rodrigues-Júnior V; Moraes-Souza H
Leuk Lymphoma; 2018 Jan; 59(1):214-220. PubMed ID: 28679297
[TBL] [Abstract][Full Text] [Related]
28. Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity.
Hay ZLZ; Slansky JE
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163755
[TBL] [Abstract][Full Text] [Related]
29. TIGIT presents earlier expression dynamic than PD-1 in activated CD8
Hu F; Wang W; Fang C; Bai C
Exp Cell Res; 2020 Nov; 396(1):112260. PubMed ID: 32890458
[TBL] [Abstract][Full Text] [Related]
30. Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.
Kis-Toth K; Comte D; Karampetsou MP; Kyttaris VC; Kannan L; Terhorst C; Tsokos GC
Arthritis Rheumatol; 2016 Jan; 68(1):164-73. PubMed ID: 26314831
[TBL] [Abstract][Full Text] [Related]
31. Th17 cells inhibit CD8
Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.
Prall F; Dührkop T; Weirich V; Ostwald C; Lenz P; Nizze H; Barten M
Hum Pathol; 2004 Jul; 35(7):808-16. PubMed ID: 15257543
[TBL] [Abstract][Full Text] [Related]
33. Adoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.
Sin JI; Kim JM; Bae SH; Lee IH; Park JS; Ryoo HM
Mol Ther; 2009 May; 17(5):906-13. PubMed ID: 19277009
[TBL] [Abstract][Full Text] [Related]
34. A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression.
Kienzle N; Buttigieg K; Groves P; Kawula T; Kelso A
J Immunol; 2002 Feb; 168(4):1672-81. PubMed ID: 11823496
[TBL] [Abstract][Full Text] [Related]
35. Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8
Xu J; Guo R; Jia J; He Y; He S
BMC Immunol; 2021 Oct; 22(1):67. PubMed ID: 34620075
[TBL] [Abstract][Full Text] [Related]
36. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
37. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.
Cao X; Cai SF; Fehniger TA; Song J; Collins LI; Piwnica-Worms DR; Ley TJ
Immunity; 2007 Oct; 27(4):635-46. PubMed ID: 17919943
[TBL] [Abstract][Full Text] [Related]
38. Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.
Koch M; Beckhove P; Op den Winkel J; Autenrieth D; Wagner P; Nummer D; Specht S; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Weitz J
Ann Surg; 2006 Dec; 244(6):986-92; discussion 992-3. PubMed ID: 17122624
[TBL] [Abstract][Full Text] [Related]
39. PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients.
Wu X; Zhang H; Xing Q; Cui J; Li J; Li Y; Tan Y; Wang S
Br J Cancer; 2014 Sep; 111(7):1391-9. PubMed ID: 25093496
[TBL] [Abstract][Full Text] [Related]
40. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
